Brendan McDonnell, Director at HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), sold 5,000 shares at $7.41 ($37K) on 2006-01-30, disclosed to the SEC on 2006-01-31.
Scheduled sale ($37k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |